Franklin Resources
ITOS

Franklin Resources’s iTeos Therapeutics ITOS Stock Holding History

Franklin Resources’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,801
Closed -$144K – 2971
2024
Q3 		$144K Sell
14,801
-32,791
-69% -$500K ﹤0.01% 2703
2024
Q2 		$706K Buy
47,592
+11,154
+31% +$160K ﹤0.01% 2088
2024
Q1 		$497K Buy
+36,438
New +$397K ﹤0.01% 2253
2023
Q3 		– Sell
-12,072
Closed -$160K – 2733
2023
Q2 		$160K Buy
+12,072
New +$172K ﹤0.01% 2440
2022
Q2 		– Sell
-6,606
Closed -$212K – 2415
2022
Q1 		$212K Buy
+6,606
New +$240K ﹤0.01% 2141
2021
Q1 		– Sell
-85,000
Closed -$2.88M – 2004
2020
Q4 		$2.88M Hold
85,000
– – ﹤0.01% 1211
2020
Q3 		$2.1M Buy
+85,000
New +$2.29M ﹤0.01% 1199

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Franklin Resources's ITOS Position: Q4 2024 in Review

Franklin Resources sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 14,801 shares — an estimated $144K sold.

Franklin Resources first reported a position in ITOS in Q3 2020 and held it in 7 quarters. The position peaked at $2.88M in Q4 2020. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Franklin Resources reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Franklin Resources sold 14,801 iTeos Therapeutics shares in Q4 2024, an estimated $144K.
  • Franklin Resources first reported a position in iTeos Therapeutics in Q3 2020 and held it in 7 quarters.
  • Franklin Resources's iTeos Therapeutics position peaked at $2.88M in Q4 2020.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Franklin Resources's 13F filing for Q4 2024, filed 12 Feb 2025.